How to prevent contrast-induced nephropathy and manage risk patients: Practical recommendations

被引:105
作者
Solomon, R
Deray, G
机构
[1] Univ Vermont, Fletcher Allen Hlth Care, Burlington, VT 05405 USA
[2] Hop La Pitie Salpetriere, Dept Nephrol, Paris, France
关键词
D O I
10.1038/sj.ki.5000375
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:S51 / S53
页数:3
相关论文
共 5 条
[1]   Contrast-induced nephropathy: Pharmacological prophylaxis [J].
Briguori, C ;
Marenzi, G .
KIDNEY INTERNATIONAL, 2006, 69 :S30-S38
[2]   Concomitant drugs with exposure to contrast media [J].
Erley, C .
KIDNEY INTERNATIONAL, 2006, 69 :S20-S24
[3]   Prevention of contrast-induced nephropathy with volume supplementation [J].
Mueller, C .
KIDNEY INTERNATIONAL, 2006, 69 :S16-S19
[4]   Follow-up of patients with contrast-induced nephropathy [J].
Solomon, R ;
Barrett, B .
KIDNEY INTERNATIONAL, 2006, 69 :S46-S50
[5]   N-acetylcysteine and contrast-induced nephropathy:: A meta-analysis of 13 randomized trials [J].
Zagler, A ;
Azadpour, M ;
Mercado, C ;
Hennekens, CH .
AMERICAN HEART JOURNAL, 2006, 151 (01) :140-145